abstract |
A pharmaceutical composition containing pemafibrate or a salt thereof or a solvate thereof and one or more selected from the group consisting of metal oxides, dihydric alcohols, esters and silicic acid compounds, and having excellent storage stability. To provide. The following components (A) and (B): (A) pemafibrate or a salt thereof or a solvate thereof; (B) at least one selected from the group consisting of the following components (B-1) to (B-4): (B-1) Metal oxide (B-2) Dihydric alcohol (B-3) Ester (B-4) Containing a silicic acid compound, and substantially the component (A) and the component (B). A pharmaceutical composition which is contained so as not to contact with each other. |